BIOVERSYS REPORTS CORPORATE HIGHLIGHTS AND FINANCIAL RESULTS FOR THE FULL YEAR 2025
BIOVERSYS AG - EXPECTS TOTAL OPERATING LOSS OF CHF 40-45 MILLION FOR FY2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.